SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA's approval of Bysanti for bipolar I disorder and schizophrenia, which has ignited community discussions about its significant market potential, extended patent protection, and the likelihood of a substantial short squeeze, further bolstering the company's pipeline.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending as the community discusses its NEAR AI initiative joining NVIDIA's Inception Program and a Grayscale S-1 filing for a Near Trust. Sentiment revolves around its potential as a leader in verifiable AI and its growing utility in cross-chain interoperability through NEAR Intents, driving accumulation despite recent price volatility.

Moo Deng

Moo Deng is trending with explosive price action and massive trading volume, sparking widespread community excitement and speculation for parabolic gains, as traders eye its low market cap for continued upward momentum.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to community speculation around the pending Supreme Court tariff ruling and an ongoing leadership vacuum. This is amplified by founder Chip Wilson's public criticisms and recent product quality concerns, which are overshadowing otherwise strong holiday sales guidance and international growth.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BNKR Crypto is trending amid a flurry of new exchange listings and expanding utility for its AI agent and BankrWallet, generating significant community excitement for its revenue-generating potential and price discovery, despite ongoing debate about its volatility and market resilience.

Memecoin on Injective taken over by the community.

Nonja

The $NONJA community is buzzing with conviction that it's the premier meme coin on the Injective blockchain, poised for leveraged gains as $INJ, an undervalued L1 with strong fundamentals and potential ETF approvals, anticipates a significant market rally. Its burned liquidity and dedicated holders underscore belief in its unruggable nature and asymmetric upside when Injective breaks out.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending after a sharp sell-off, as Anthropic's new Claude Code Security tool has fueled community discussion and investor concern over AI's potential to disrupt traditional cybersecurity valuations, despite many arguing CRWD's core offerings are distinct from code scanning.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is trending ahead of its anticipated business update and earnings, with community discussion fueled by the launch of its Indensity battery architecture and cryptic marketing hinting at major developments. Investors are debating if the company's US-made, non-flammable zinc battery technology is set to capture significant demand from AI data centers and grid modernization, or if past execution risks and valuation concerns will lead to volatility.

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care Inc

Tandem Diabetes Care (TNDM) is seeing significant trending activity following a robust Q4 earnings beat that exceeded revenue estimates and reported a narrower loss, coupled with reaffirmed guidance. The community is buzzing about the stock's strong upward momentum, driven by these positive results and ongoing strategic shifts like the move to a 'pay as you go' model and new product integrations, with many debating whether the rally will continue or if profit-taking is imminent.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

SWEAT CRYPTO is trending with heightened community chatter centered on its move-to-earn utility and long-term recovery potential, as investors express both optimism for its future rise and concerns over its current low valuation. Discussion highlights its core function of rewarding physical activity through staking and in-app redemptions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.

MDCX
Medicus Pharma Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MDCX News

MDCXMedicus Pharma Ltd